García-Sevilla JA - Search Results

1

Neuroprotective Effects of a Structurally New Family of High Affinity Imidazoline I₂ Receptor Ligands.

Abás S, Erdozain AM, Keller B, Rodríguez-Arévalo S, Callado LF, García-Sevilla JA, Escolano C. Abás S, et al. ACS Chem Neurosci. 2017 Apr 19;8(4):737-742. doi: 10.1021/acschemneuro.6b00426. Epub 2017 Jan 4. ACS Chem Neurosci. 2017. PMID: 28029766

2

Molecular characterization and isolation of a 45-kilodalton imidazoline receptor protein from the rat brain.

Escribá PV, Ozaita A, Miralles A, Reis DJ, García-Sevilla JA. Escribá PV, et al. Brain Res Mol Brain Res. 1995 Sep;32(2):187-96. doi: 10.1016/0169-328x(95)00074-3. Brain Res Mol Brain Res. 1995. PMID: 7500830 Free article.

3

LSL 60101, a selective ligand for imidazoline I2 receptors, on glial fibrillary acidic protein concentration.

Alemany R, Olmos G, Escribá PV, Menargues A, Obach R, García-Sevilla JA. Alemany R, et al. Eur J Pharmacol. 1995 Jul 4;280(2):205-10. doi: 10.1016/0014-2999(95)00214-6. Eur J Pharmacol. 1995. PMID: 7589187

4

Age-dependent increases of immunoreactive imidazoline receptors in the human brain: possible association of a 29/30 kDa protein with the I2-imidazoline receptor identified by [3H]idazoxan.

García-Sevilla JA, Sastre M, Escribá PV. García-Sevilla JA, et al. Neurosci Lett. 1995 Jan 23;184(2):133-6. doi: 10.1016/0304-3940(94)11188-o. Neurosci Lett. 1995. PMID: 7724047

5

The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.

Alemany R, Olmos G, García-Sevilla JA. Alemany R, et al. Br J Pharmacol. 1995 Feb;114(4):837-45. doi: 10.1111/j.1476-5381.1995.tb13280.x. Br J Pharmacol. 1995. PMID: 7773544 Free PMC article.

6

Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissues.

Escribá PV, Sastre M, Wang H, Regunathan S, Reis DJ, García-Sevilla JA. Escribá PV, et al. Neurosci Lett. 1994 Aug 29;178(1):81-4. doi: 10.1016/0304-3940(94)90295-x. Neurosci Lett. 1994. PMID: 7816347 Free article.

7

Non-adrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer's disease.

Ruiz J, Martín I, Callado LF, Meana JJ, Barturen F, García-Sevilla JA. Ruiz J, et al. Neurosci Lett. 1993 Sep 17;160(1):109-12. doi: 10.1016/0304-3940(93)90925-b. Neurosci Lett. 1993. PMID: 7902542

8

The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain.

Olmos G, Alemany R, Escriba PV, García-Sevilla JA. Olmos G, et al. Br J Pharmacol. 1994 Apr;111(4):997-1002. doi: 10.1111/j.1476-5381.1994.tb14842.x. Br J Pharmacol. 1994. PMID: 8032628 Free PMC article.

9

Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.

Miralles A, Olmos G, Sastre M, Barturen F, Martin I, Garcia-Sevilla JA. Miralles A, et al. J Pharmacol Exp Ther. 1993 Mar;264(3):1187-97. J Pharmacol Exp Ther. 1993. PMID: 8095548

10

No effect of genetic obesity and mazindol on imidazoline I2 binding sites in the brain of Zucker rats.

Miralles A, Ribas C, Olmos G, García-Sevilla JA. Miralles A, et al. Eur J Pharmacol. 1993 Oct 26;243(3):305-8. doi: 10.1016/0014-2999(93)90191-j. Eur J Pharmacol. 1993. PMID: 8276084

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters